Publication | Closed Access

Randomized, double-blind pilot study of transendocardial injection of autologous aldehyde dehydrogenase–bright stem cells in patients with ischemic heart failure

Heart FailureCardiovascular DiseaseMyocardial InfarctionStem CellsIschemic Heart FailureStem Cell ResearchStem-cell TherapyBiomedical EngineeringTransendocardial InjectionStem Cell BiologyMedicineCell TransplantationCardiologyDouble-blind Pilot Study